Neurological deficit (e.g. paresthesia) · patients undergoing surgery with femoral artery approach
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of VTE ( · people with distal DVT
Anticoagulant leads to lower recurrence of VTE ( compared with no intervention or placebo (high certainty).
1 finding from 1 review
Recurrence of DVT ( · people with distal DVT
Anticoagulation for three months or more leads to lower recurrence of DVT ( compared with anticoagulation (high certainty).
1 finding from 1 review
PE ( · people with distal DVT
Anticoagulation for three months or more showed no clear difference in PE ( compared with anticoagulation (low certainty).
1 finding from 1 review
Clinically relevant non‐major bleeding Treatment duration 28 ‐ 42 days · people with distal DVT
Anticoagulation for three months or more showed no clear difference in clinically relevant non‐major bleeding ( compared with anticoagulation (low certainty).
1 finding from 1 review
Overall mortality · people with distal DVT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality related to PE ( · people with distal DVT
1 finding from 1 review
Major bleeding · people with distal DVT
Anticoagulant showed no clear difference in major bleeding ( compared with no intervention or placebo (low certainty).
1 finding from 1 review
Recurrence of DVT ( · people with distal DVT
Anticoagulant leads to lower recurrence of DVT ( compared with no intervention or placebo (high certainty).
1 finding from 1 review
PE ( · people with distal DVT
Anticoagulant showed no clear difference in PE ( compared with no intervention or placebo (low certainty).
1 finding from 1 review
Clinically relevant non‐major bleeding Treatment duration 28 ‐ 42 days · people with distal DVT
Anticoagulant leads to higher clinically relevant non‐major bleeding ( compared with no intervention or placebo (high certainty).
1 finding from 1 review
Overall mortality ( · people with distal DVT
Anticoagulant showed no clear difference in overall mortality ( compared with no intervention or placebo (low certainty).
1 finding from 1 review
Mortality related to PE ( · people with distal DVT
1 finding from 1 review
Recurrence of VTE ( · people with distal DVT
Anticoagulation for three months or more leads to lower recurrence of VTE ( compared with anticoagulation (high certainty).
1 finding from 1 review
Major bleeding · people with distal DVT
Anticoagulation for three months or more showed no clear difference in major bleeding ( compared with anticoagulation (low certainty).
1 finding from 1 review
Intervention not reported
Severity of post‐thrombotic syndromeb ( · adults with PTS
1 finding from 1 review
Intervention not reported
Adverse effects ( · adults with PTS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Patient satisfaction and quality of life · adults with PTS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Compliance rate · adults with PTS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Severity post‐thrombotic syndromeb ( · adults with PTS
The intervention showed no clear difference in severity post‐thrombotic syndromeb ( (low certainty).
1 finding from 1 review